- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x QJ9: 1-{(3S)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl}-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one(Non-covalent)
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 8 residues within 4Å:- Chain A: E.296, A.299, L.300, K.303, F.322, E.324, Y.327, R.328
Ligand excluded by PLIPEDO.3: 3 residues within 4Å:- Chain A: R.42, F.404, V.405
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: N.116, K.117, N.120
Ligand excluded by PLIPEDO.6: 2 residues within 4Å:- Chain A: K.454, H.457
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: Y.337, E.339, K.358
Ligand excluded by PLIPEDO.8: 7 residues within 4Å:- Chain A: A.283, V.284, Q.285, I.459, N.506, C.507, D.509
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: R.46, G.47, T.50
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: Q.54, K.55, A.58
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: V.517, T.518, T.519, T.581
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain B: A.52, K.55, Q.56, S.59, T.123, S.124, F.209
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain B: Y.338, D.341, I.376, T.480, S.500, Y.501, L.504, Y.505
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: S.201, F.202, C.408, P.492, G.493
- Ligands: QJ9.13
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain B: T.84, L.85, P.86, Q.89
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: V.517, T.518, T.519, T.581
Ligand excluded by PLIPEDO.20: 1 residues within 4Å:- Chain B: R.351
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain B: P.86, L.88, Q.89, E.296
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: R.53, F.404
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: R.352, T.521, E.523, D.524
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: N.375, Y.378
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain B: R.360, A.363, L.579
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: M.199, I.246, G.276, L.286
Ligand excluded by PLIP- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 4 residues within 4Å:- Chain A: R.445, P.446, R.447, K.451
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.442, A:R.445, A:K.451
- Water bridges: A:R.445
GOL.16: 6 residues within 4Å:- Chain B: L.88, E.296, L.300, K.303, E.324, R.328
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.296, B:E.296, B:K.303, B:E.324, B:R.328
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Min, X. et al., Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH). Proc.Natl.Acad.Sci.USA (2011)
- Release Date
- 2011-04-27
- Peptides
- Fatty-acid amide hydrolase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x QJ9: 1-{(3S)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl}-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one(Non-covalent)
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Min, X. et al., Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH). Proc.Natl.Acad.Sci.USA (2011)
- Release Date
- 2011-04-27
- Peptides
- Fatty-acid amide hydrolase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B